The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-24), Egyptian International Pharmaceutical Investments's share price is E£43.18. Egyptian International Pharmaceutical Investments's Book Value per Share for the quarter that ended in Dec. 2023 was E£28.62. Hence, Egyptian International Pharmaceutical Investments's PB Ratio of today is 1.51.
The historical rank and industry rank for Egyptian International Pharmaceutical Investments's PB Ratio or its related term are showing as below:
CAI:PHAR'
s PB Ratio Range Over the Past 10 Years
Min: 0.94 Med: 2.44 Max: 15.53
Current: 1.51
During the past 13 years, Egyptian International Pharmaceutical Investments's highest PB Ratio was 15.53. The lowest was 0.94. And the median was 2.44.
CAI:PHAR's PB Ratio is ranked better than 58.94% of 962
companies
in the Drug Manufacturers industry
Industry Median: 1.91
vs CAI:PHAR: 1.51
During the past 12 months, Egyptian International Pharmaceutical Investments's average Book Value Per Share Growth Rate was 13.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 8.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 5.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 9.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Egyptian International Pharmaceutical Investments was 18.70% per year. The lowest was 2.10% per year. And the median was 5.65% per year.
Back to Basics: PB Ratio
Egyptian International Pharmaceutical Investments PB Ratio Historical Data
The historical data trend for Egyptian International Pharmaceutical Investments's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Egyptian International Pharmaceutical Investments Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Egyptian International Pharmaceutical Investments's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Egyptian International Pharmaceutical Investments PB Ratio Distribution
For the Drug Manufacturers industry and Healthcare sector, Egyptian International Pharmaceutical Investments's PB Ratio distribution charts can be found below:
* The bar in red indicates where Egyptian International Pharmaceutical Investments's PB Ratio falls into.
Egyptian International Pharmaceutical Investments PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Egyptian International Pharmaceutical Investments's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Egyptian International Pharmaceutical Investments (CAI:PHAR) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Egyptian International Pharmaceutical Investments PB Ratio Related Terms
Thank you for viewing the detailed overview of Egyptian International Pharmaceutical Investments's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Egyptian International Pharmaceutical Investments (CAI:PHAR) Business Description
Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, non-traditional dosage forms including soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. It exports its products to Arab countries, African, Asian and East European Countries. Its products portfolio includes antibiotics, anesthetics, analgesics, antihypertensives, cholesterol-lowering medications, ophthalmic products, blood substitutes and restoratives, dermatological drugs and vitamins. Some of its products are Vasotec, Co-vasotec, Flumox, and Cefotax.
Egyptian International Pharmaceutical Investments (CAI:PHAR) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CAI:PHAR has been successfully added to your 